70+ Key Companies Advancing in Dry Age-Related Macular Degeneration Clinical Trial Therapeutic Space | DelveInsight
DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...
Apellis Pharmaceuticals CFO sells shares worth $93,953
Timothy Eugene Sullivan, the Chief Financial Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold 3,088 ...
Apellis Pharmaceuticals' chief commercial officer sells shares worth $101,103
Adam J. Townsend, Chief Commercial Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.87 billion market cap biotech company, recently sold 3,323 shares of the company's common stock. The ...
FiercePharma4h
As Super Bowl nears, TV data show GLP-1 game day ads enjoyed a big year
Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...
The Australian Financial Review18h
Neuren Pharmaceuticals Limited
Biopharmaceutical company developing drugs for neurological disorders.
Indiatimes20h
Aurobindo Pharma Share Price
Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...
Indiatimes21h
Natco Pharma Share Price
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 22,532.02 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...